| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 4. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | clindamycin/benzoyl peroxide (Duac®) |
| Formulation | 10 mg/g/30 mg/g gel |
| Reference number | 1849 |
| Indication | Topical treatment of mild to moderate acne vulgaris, particularly inflammatory lesions, in adults and adolescents aged 12 years and above |
| Company | GlaxoSmithKline |
| BNF chapter | Skin |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/02/2013 |